Trial search - ClinicalTrials.eu

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

Study of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment

Not yet recruiting

2 1 1
Investigated drugs:
- (2S)-2-CYCLOPENTYL-2-[(5S)-2-[(2R,3R)-3-CYCLOPROPYL-1-METHYLAZIRIDINE-2-CARBONYL]-2,7-DIAZASPIRO[4.4]NONAN-7-YL]-N-[(6S,8S,14S)-21-[5-(4-CYCLOPROPYLPIPERAZIN-1-YL)-2-[(1S)-1-METHOXYETHYL]PYRIDIN-3-YL]-18,18-DIMETHYL-9,15-DIOXO-22-(2,2,2-TRIFLUOROETHYL)-5,16-DIOXA-2,10,22,28-TETRAZAPENTACYCLO[18.5.2.12,6.110,14.023,27]NONACOSA-1(26),20,23(27),24-TETRAEN-8-YL]ACETAMIDE
+3
Study of sacituzumab govitecan and zimberelimab treatment before and after surgery for patients with resectable non-small cell lung cancer

Not yet recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Zimberelimab
- Sacituzumab Govitecan
A study of PF-08634404 and sigvotatug vedotin in patients with advanced solid tumors

Not yet recruiting

1 1 1
Investigated drugs:
- HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST PD-L1 CONJUGATED TO MONOMETHYL AURISTATIN E VIA A VALINE-CITRULLINE LINKER
- SIGVOTATUG VEDOTIN
Study of 18F-FAPI-74 PET/CT Imaging to Detect Cancer Spread in Patients with Non-Small Cell Lung Cancer

Not yet recruiting

2 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- [Al[18F]F]Fapi-74
A study comparing 68Ga-FAPI-46 PET scan with standard 18F-FDG PET scan and brain MRI for staging in patients with newly diagnosed non-small cell lung cancer

Not yet recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
- Fludeoxyglucose (18F)
Testing OMTX705 Combined with Carboplatin, Pemetrexed, and Tislelizumab for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer

Not yet recruiting

1 1 1 1
Investigated drugs:
Study of Izalontamab Brengitecan versus Platinum-based Chemotherapy for Patients with EGFR-mutated Non-small Cell Lung Cancer after EGFR Inhibitor Treatment

Not yet recruiting

4 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
+4
Study of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery

Not yet recruiting

3 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
+3
Study of amivantamab and pemetrexed for patients with non-small cell lung cancer who have EGFR exon20 insertion mutations and cannot receive platinum therapy

Not yet recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Amivantamab
- Pemetrexed
Evaluation of Datopotamab Deruxtecan in Patients with Non-Squamous Non-Small Cell Lung Cancer and Active Brain Metastases

Not yet recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:

Find clinical trials in your area

Matched clinical trials

We use cookies